Abstract
Cardiac hypertrophy has been observed in newborn infants treated with dexamethasone (DEX). This study was undertaken to examine whether DEX-induced hypertrophy in newborn rats is associated with redistribution of cardiac myosin heavy chain (MHC) isoforms and if so, the effects involve transcriptional regulation. Newborn rats were injected with either DEX (1 mg/kg/day; s.c.) or equivalent volume normal saline for 1, 3, 5, 7 or 9 days. Hypertrophy was quantified by heart dry/wet wt ratios, heart/body wt ratios, and total protein content of the myocardium. Changes in the expression of cardiac MHC mRNA were characterized by northern blot and slot blot analyses, using isoform specific probes for a- and β-MHC genes. DEX effect on α-MHC gene transcription was analyzed by transiently transfecting various α-MHC promoter/CAT reporter constructs into primary cultures of cardiac myocytes derived from one day old rat pups. DEX administration into newborn rats produced significant cardiac hypertrophy ranging from 23% at day 1 to 59% at 9 days. The hypertrophy was accompanied by immediate increase (83%) in steady state level of the α-MHC mRNA within one day and a maximum increase (148%) at 7 days of treatment. The steady state level of β-MHC mRNA declined by 25% at day 1 and a maximum decrease of 54% at day 7 of DEX treatment. The changes in MHC mRNA were also reflected in their protein levels as determined by V1 and V3 isozyme analysis. DEX treatment of primary cultures of cardiomyocytes following transfection with a-MHC promoter/CAT reporter constructs resulted in increased CAT expression in a dose dependent manner. The minimum α-MHC gene sequences responding to DEX treatment were located between the -200 to -74-bp region of the gene, resulting in 2-fold and 6-fold activation of CAT reporter after 0.05 and 0.1 mM doses of DEX, respectively. Our data indicate that DEX induced cardiac hypertrophy in newborn rats is accompanied by increased expression of α-MHC and decreased expression of β-MHC. The α-MHC effects are mediated in part through transcriptional mechanisms.
Similar content being viewed by others
References
Cummings JJ, D'Eugenio DB, Gross SJ: A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. New Engl J Med 320: 1504-1510, 1989
Werner JC, Sicard RE, Hansen WR, Solomon E, Cowett RM, Oh W: Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia. J Pediatr 120: 286-291, 1992
Bensky AS, Kothadia JM, Covitz W: Cardiac effect of dexamethasone in very low birth weight infants. Pediatrics 97: 818-821, 1996
Ohning BL, Fyfe DA, Riedel PA: Reversible obstructive hypertrophic cardiomyopathy after dexamethasone therapy for bronchopulmonary dysplasia. Am Heart J 125: 253-258, 1993
Haney I, Lachance C, van Doesburg NH, Fouron JC: Reversible steroidinduced hypertrophic cardiomyopathy with left ventricular outflow tract obstruction in two newborns. Am J Perinatology 12: 271-274, 1995
Torres A, Belser WW III, Umeda PK, Tucker D: Indicators of delayed maturation of rat heart treated prenatally with dexamethasone. Ped Res 42: 139-144, 1997
Bian X, Briggs MM, Schachat FH, Seidler FJ, Slotkin TA: Glucocorticoids accelerated the ontogenetic transition of cardiac ventricular myosin heavy-chain isoform expression in the rat: Promotion by prenatal exposure to a low dose of dexamethasone. J Dev Phys 18: 35-42, 1992
Sicard RE, Werner JC: Dexamethasone induces a transient relative cardiomegaly in neonatal rats. Ped Res 31: 359-363, 1992
Kurowski TT, Czerwinski SM: Glucocorticoid modulation of cardiac mass and protein. Med Sci Sports Exer 22: 312-315, 1990
Sicard RE, Werner JC: Biochemical correlates of dexamethasoneinduced relative cardiomegaly in neonatal rats. In vivo 9: 75-80, 1995
Clark AF, DeMartino GN, Wildenthal K: Effects of glucocorticoid treatment on cardiac protein synthesis and degradation. Am J Physiol 250: C821-C827, 1986
Gupta M, Gupta MP, Arcilla RA, Zak R: Cardiomyocytes and nonmuscle cells in cardiac hypertrophy: A molecular perspective. Prog Ped Cardiol 9: 183-197, 1999
Kariya K, Karns LR, Sampson PC: An enhancer core element mediates stimulation of the rat β myosin heavy chain promoter by an α1-adrenergic agonist and activated protein kinase C in hypertrophy of cardiac myocytes. J Biol Chem 269: 3775-3782, 1994
Gupta MP, Gupta M, Zak R: An E-Box/M-CAT motif and cognate binding proteins regulate the basal muscle specific and cAMP inducible expression of rat cardiac a-myosin heavy chain gene. J Biol Chem 269: 29677-29687, 1994
Izumo S, Nadal-Ginard B, Mahdavi V: All members of the myosin heavy chain multigene family respond to thyroid hormone in a highly tissue-specific manner. Science 231: 597-600, 1986
Chizzonite RA, Zak R: Regulation of myosin isoenzyme composition in fetal and neonatal rat ventricle by endogenous thyroid hormones. J Biol Chem 259: 12628-12632, 1984
Izumo S, Lompre AM, Matsuoka R et al.: Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. J Clin Invest 79: 970-977, 1987
Holubarsch CH, Goulette RP, Litten RZ, Martin BJ, Mulieri LA, Alpert NR: The economy of force development. Myosin isozyme pattern and 173 myofibrillar ATPase activity in normal and hypertrophied rat myocardium. Circ Res 56: 78-86, 1985
Jones WK, Grupp IL, Doetschman T, Grupp G, Osinaska H, Hewett TE, Biovin G, Gulick J, Ng WA, Robbins J: Ablation of the murine α-myosin heavy chain gene leads to dosage effects and functional deficits in the heart. J Clin Invest 98: 1906-1917, 1996
Lowes BD, Minobe W, Abraham WT et al.: Changes in gene expression in the intact human heart: Down regulation of α-myosin heavy chain in hypertrophied failing myocardium. J Clin Invest 100: 2315-2324, 1997
Nakao K, Minobe W, Roden R, Bristow RM, Leindand LA: Myosin heavy chain gene expression in the human heart failure. J Clin Invest 100: 2362-2370, 1997
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with folin phenol reagent. J Biol Chem 193: 265-275, 1951
Chirgwin JM, Prizybyla AE, McDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299, 1979
Clark WA, Chizzonite RA, Everett AW, Rabinowitz M, Zak R: Species correlation between cardiac isomyosins: A comparison of electrophoretic and immunological properties. J Biol Chem 257: 5449-5454, 1982
Gupta MP, Gupta M, Zak R, Sukhatme VP: Egr-1, a serum-inducible zinc finger protein, regulates transcription of the rat cardiac alpha myosin heavy chain gene. J Biol Chem 266: 12813-12816, 1991
Gupta M, Zak R, Libermann TA, Gupta MP: Tissue-restricted expression of the cardiac α-myosin heavy chain gene is controlled by a downstream repressor element containing a palindrome of two Etsbinding sites. Mol Cell Biol 18: 7243-7258, 1998
Chen CA, Okayama H. Calcium phosphate-mediated gene transfer: A highly efficient transfection system for stably transforming cells with plasmid DNA. Biotechniques 6: 632-638, 1988
Rosenthal N: Identification of regulatory elements of cloned genes with transcriptional assays. Meth Enzymol 152: 704-720, 1987
Miyabo S, Yanagisawa KI, Ooya E, Hisada T, Kishida S: Ontogeny of circadian corticosterone rhythm in female rats: Effects of periodic maternal deprivation and food restriction. Endocrinology 106: 636-642, 1980
Clark AF, Tandler B, Vignos PJ: Glucocorticoid-induced alterations in the rabbit heart. Lab Invest 47: 603-610, 1982
Hicks DC, Lee A, Kilgore BS et al.: Glucocorticoid effects on embryonic chick heart. Ann Clin Lab Sci 12: 477-483, 1982
Griffin EE, Wildenthal K: Regulation of cardiac protein balance by hydrocortisone: interaction with insulin. Am J Physiol 234: E306-E313, 1978
Levinovitz A, Norstedt G: Developmental and steroid hormonal regulation of insulin-like growth factor II expression. Mol Endocrinol 3: 797-803, 1989
Brem AS, Bina RB, Klinger JR, King T, Werner JC: Glucocorticoid metabolism in the newborn heart. Proc Soc Exp Biol Med 209: 146-151, 1995
Calovini T, Haase H, Morano I: Steroid-hormone regulation of myosin subunit expression in smooth and cardiac muscle. J Cell Biochem 59: 69-78, 1995
Sheer D, Morkin E: Myosin isoenzyme expression in rat ventricle: Effects of thyroid hormone analogs, catecholamine, glucocorticoids and high carbohydrate diet. J Pharmacol Exp Ther 220: 872-878, 1984
Schaible TF, Malhotra A, Ciambrone G, Scheuer J: The effects of gonadectomy on left ventricular function and cardiac contractile proteins in male and female rats. Circ Res 54: 38-49, 1984
Scheuer J, Malhotra A, Schaible TF, Capasso J: The effects of gonadectomy and hormonal replacement on rat hearts. Circ Res 61: 12-19, 1987
Czerwinski SM, Kurowski TT, McKee EE, Zak R, Hickson RC: Myosin heavy chain turnover during cardiac mass changes by glucocorticoids. J Appl Physiol 70: 300-305, 1991
Bruna RD, Ries S, Himmelstoss C, Kurtz A: Expression of cardiac angiotensin receptor genes in rat hearts is regulated by steroids but not by angiotensin II. J Hypertens 13: 763-769, 1995
Danberg J, Grekin RJ: Corticoid regulation of atrial natriuretic factor secretion and gene expression. Am J Physiol 263: H1377-H1381, 1992
Oikarinen A, Makela J, Vuorio T, Vuorio E: Comparison of collagen gene expression in the developing chick embryo tendon and heart. Tissue and development time-dependent action of dexamethasone. Biochem Biophys Acta 1089: 40-46, 1991
Argentin S, Sun YL, Lihrmann I, Schmidt TJ, Drouin J, Nemer M: Distal cis-acting promoter sequences mediate glucocorticoid stimulation of cardiac natriuretic factor gene transcription. J Biol Chem 266: 23315-23322, 1991
Parrelli JM, Meisler N, Cutroneo KR: Identification of glucocorticoid response element in the human transforming growth factor beta 1 gene promoter. Int J Biochem Cell Biol 30: 623-627, 1998
Subramaniam N, Carins W, Okret S: Glucocorticoids repress transcription from a negative response element recognized two homeodomain-containing proteins, pbx and Oct-1. J Biol Chem 273: 23567-23574, 1998
Petz LN, Nardulli AM, Horwitz KB, Freedman LP, Shapiro DJ: DNA binding is induced by binding of the glucocorticoid receptor DNA binding domain and progestrone receptors to their response element. J Ster Biochem Mol Biol 60: 31-41, 1997
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Muangmingsuk, S., Ingram, P., Gupta, M.P. et al. Dexamethasone induced cardiac hypertrophy in newborn rats is accompanied by changes in myosin heavy chain phenotype and gene transcription. Mol Cell Biochem 209, 165–174 (2000). https://doi.org/10.1023/A:1007128300430
Issue Date:
DOI: https://doi.org/10.1023/A:1007128300430